Delivery Order SPE2DE24D0013-SPE2D626F155P
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,709.36 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, identified as XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions. The...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,417.52 on October 22, 2025, by the Defense Logistics Agency Medical Supply Chain under a firm fixed-price contract structure. The delivery order, designated XPRSMVP-10, is scheduled for completion by October 29, 2025, with performance occurring at Cepheid's Sunnyvale facility. This award was made without a set-aside designation, reflecting Cepheid's...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F155PDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,373.44 to Cepheid Inc. on November 13, 2025, for delivery to the company's headquarters in Sunnyvale, California. This firm fixed-price delivery order, designated XPRSMVP-10, is structured as a non-competitive award with an ultimate completion date of November 20, 2025. The contract represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions, building upon the company's extensive portfolio of federal healthcare contracts across the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and other federal agencies. Cepheid specializes in advanced molecular diagnostic systems and reagents, with particular expertise in rapid infectious disease detection through its GeneXpert diagnostic platform. The company's federal customer base relies on Cepheid for diagnostic testing supplies, reagents, test kits for conditions including COVID-19, influenza, and tuberculosis, as well as equipment maintenance and support services. The modest ceiling value of this particular delivery order suggests it represents a routine procurement of diagnostic supplies or testing materials to support ongoing Medical Supply Chain operations. This award reinforces Cepheid's competitive positioning in the federal molecular diagnostics procurement market and aligns with the Defense Logistics Agency's mission to provide critical medical supplies to the Department of Defense and related federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 11/13/25 |